SAShahlaa Zuhair Abdul-Majeed

Shahlaa Zuhair Abdul-Majeed

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shahlaa Zuhair Abdul-Majeed has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synergistic Effects of Vitamin D And Omega-3 On Glycemic Regulation, Lipid Metabolism, and Oxidative Stress in Type-1 Diabetic Mice

    by Shahlaa Zuhair Abdul-Majeed, Jumana Suhban Sulaiman Almallah, Shuhad Yaseen

    Background: Vitamin D and omega-3 (ω-3) have garnered significant attention in the scientific community due to their ability to exert various non-classical activities on the body, and multifaceted roles in maintaining overall health. Hence, a good understanding of the potential effect of vitamin D and ω-3 in developing and progressing type-1 diabetes mellitus (T1DM) can assist in controlling clinical advancement of the disease. Aims: The current study aimed to experimentally induce T1DM to investigate the role of vitamin D, omega-3, and their combination on the activity of lipid profile, liver enzymes, and antioxidant markers. Materials and methods: A total of 75 young male mice were divided equally into five groups. Initially, T1DM was induced in PC, EG1, EG2, and EG3 by a single high dose of streptozotocin. Mice were treated daily with vitamin D (EG1), ω-3 (EG2), and a combination of both (EG3). After 12 weeks, mice were euthanized and blood was collected to be tested using quantitative specific ELISA kits for the measurement of different blood biomarkers. Results: In comparison to the values of PC, administration of vitamin D for mice of EG1 and ω-3 for mice of EG2 significantly lowered the levels of blood glucose, total cholesterol, LDL, triglyceride, ALT, AST, and MDA, as well as increasing the concentrations of HDL, catalase, GPX, and SOD. The highest ameliorative effect was shown in mice of EG3 that were administered a combination of vitamin D and ω-3. Conclusion: This study may represent the first study in Iraq that investigates the effect of vitamin D and ω-3 on the health status of T1DM in mice. However, the translation of these findings into clinical practice remains a challenge, underscoring the need for continued investigation to fully understand the multifaceted impact of vitamin D on human health.

  • Open Access

    Design, Synthesis, Characterization and Preliminary Evaluation of New 1H-benzo[d]imidazole-1yl-derivatives as Acetylcholine Esterase Inhibitors

    by Shuhad Yaseen, Shahlaa Zuhair Abdul-Majeed, Sarah Ashour Hamood

    Background: Alzheimer disease (AD) is the most common type of dementia, which is still a problem that everyone must deal with. In a continuous effort to find effective treatments, the new candidates for AD therapy have the capacity to scavenge excessive levels of free radicals and inhibit acetylcholinesterase (AChE). Objectives: This study focuses on synthesizing and biologically evaluating novel hybrid compounds (1-3) as acetylcholine esterase inhibitors. Methods: The benzimidazole has been added and then coupled with coumaric acid, cinnamic acid, and lipoic acid as conjugates, which are expected to have dual action as acetylcholinesterase inhibitors and antioxidants. The synthesis of benzimidazole derivatives (1-3) was accomplished and then characterized using 1H-NMR and elemental analysis. Additionally, their characteristics were assessed in vitro against the AChE enzyme. Results: The new compounds produced a potent inhibitory activity that may serve as a lead molecule for the synthesis of novel anti-AD molecules. Compound-1 has an inhibition percentage that is close to that of the authorized medication galantamine (95.386%), whereas compound-3 has the lowest inhibition percentage (88.647%). Conclusions: A very good yield was achieved during the synthesis of the benzimidazole derivatives (1-3) from the starting material. They can serve as potential candidates for acetylcholine esterase inhibitors.